President Joe Biden signed an executive order to help people travel between states for an abortion; Eli Lilly was ordered to pay $61 million after allegedly underpaying the Medicaid drug rebate program; CVS plans to acquire or take a stake in a primary care industry by the end of 2022.
President Joe Biden signed an executive order yesterday laying the foundation for Medicaid to assist people in travelling between states to access an abortion, the Associated Press reported. Currently, it is illegal to use federal funding toward abortions unless the pregnant person’s life is at risk or the pregnancy resulted from rape or incest. To get around this, HHS would invite states where abortion is legal to apply to use Medicaid funds to “provide reproductive healthcare to women who live in states where abortion is banned,” according to the White House. Details of the order are still being finalized.
A federal court jury ordered Eli Lilly to pay $61 million for skimping on payments to the Medicaid drug rebate program, STAT News reported. This news follows nearly a decade of legal battles in which Lilly was accused of failing to pay rebates in full between 2005 and 2016 and making false statements to CMS about how much the company charged distributors for its drugs. According to the jury, Lilly intentionally underpaid rebates to the program, which resulted in financial losses for the program as a whole and Medicaid agencies in 26 states.
CVS announced its plans to either acquire or take a stake in a primary care company by the end of 2022, CNBC reported. CVS currently has touchpoints across the health care industry, including Aetna, Caremark, and its own MinuteClinic urgent care locations. According to Karen Lynch, CEO of CVS, the company is looking to partner with a health care provider with strong management and tech experience that has potential to grow quickly, as the company’s competition with Amazon and Walgreens intensifies.
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Alzheimer Disease and Related Dementias Cause Surging Economic Burden for Minoritized Communities
June 5th 2025African American and Latino older adults with Alzheimer disease and related dementias and their families are likely to face disproportionately high burdens, primarily associated with unpaid caregiving, suggesting the need for policies that may reduce economic burdens for all US residents.
Read More
Use of Voluntary Alignment in the Next Generation ACO Model
June 5th 2025Use of voluntary alignment attribution by Next Generation Accountable Care Organization (ACO) participants was limited. The authors highlight the reasons and describe organizational use cases via a mixed-methods approach.
Read More